CNS pipeline · person
Paul Burgess
Chief Business Development and Strategic Operations Officer of Cerevel Therapeutics, appointed effective June 2023. Previously Chief Operating Officer and Chief Legal Officer of Translate Bio prior to its 2021 acquisition by Sanofi.
- 1 company
Current roles
- Cerevel TherapeuticsChief Business Development and Strategic Operations Officer · Executive2023–present
Appears with
People sharing a company with Paul.
- Adam Koppel · Cerevel Therapeutics
- Christopher Gordon · Cerevel Therapeutics
- Deborah Baron · Cerevel Therapeutics
- Deval Patrick · Cerevel Therapeutics
- Doug Giordano · Cerevel Therapeutics
- Gabrielle Sulzberger · Cerevel Therapeutics
- John Renger · Cerevel Therapeutics
- Kathleen Tregoning · Cerevel Therapeutics
- Kenneth DiPietro · Cerevel Therapeutics
- Marijn Dekkers · Cerevel Therapeutics
- Mark Bodenrader · Cerevel Therapeutics
- N. Anthony Coles · Cerevel Therapeutics
- Norbert G. Riedel · Cerevel Therapeutics
- Raymond Sanchez · Cerevel Therapeutics
- Ron Renaud · Cerevel Therapeutics
- Ruth McKernan · Cerevel Therapeutics
- Scott Akamine · Cerevel Therapeutics
- Suneet Varma · Cerevel Therapeutics
- Susan Altschuller · Cerevel Therapeutics
People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.